Heartcore Enterprises, Inc. current report, 01 November 2023

Heartcore Enterprises, Inc. — Form 8-K Summary

Business Context and Reporting Period

Heartcore Enterprises, Inc. filed a current report under Item 5.02 regarding changes to its board and board committee assignments. The reported events occurred on November 1 and November 2, 2023; the filing was signed and dated November 7, 2023. The company is incorporated in Delaware, has its principal executive offices in Tokyo, Japan, and trades on the Nasdaq Capital Market under the symbol HTCR.

Financial Metrics

This filing does not provide revenue, profit, cash flow, margins, debt, liquidity, or other operating or financial metrics.

Material Changes

  • Yoshitomo Yamano resigned from the board, effective immediately on November 2, 2023. The filing states that the resignation was not due to any disagreement with the company regarding its operations, policies, or practices.
  • Heather Neville was appointed to the board’s Audit Committee on November 1, 2023.
  • The company entered into an amended and restated Independent Director Agreement with Ms. Neville.

Director Compensation and Other Terms

  • Annual director compensation: $50,000, paid quarterly.
  • Annual Audit Committee compensation: $4,000; an additional $3,000 is payable if Ms. Neville serves as committee chair.
  • Annual Compensation Committee compensation: $4,000 while serving on that committee.
  • Annual Nominating Committee compensation: $3,000 while serving on that committee.
  • The agreement provides for reimbursement of reasonable out-of-pocket expenses, customary confidentiality and intellectual-property provisions, and indemnification and insurance protections. Certain indemnification and coverage protections continue for at least six years after the agreement ends.

Guidance, Outlook, Risks, and Unusual Items

The filing provides no financial guidance, operating outlook, contingencies, or risk-factor updates. The principal unusual items are the board resignation, Audit Committee appointment, and related director compensation agreement. The agreement itself is not included as an exhibit in this filing and is expected to be filed with the company’s next periodic report.

Investor Verification Points

  • Verify the effective date of Yoshitomo Yamano’s resignation and the resulting board and committee composition.
  • Review the Independent Director Agreement when filed, including compensation, indemnification, and expense-reimbursement terms.
  • Assess any subsequent changes to the Audit, Compensation, and Nominating Committees.
  • Consult the company’s next periodic report for financial performance, liquidity, debt, and operating outlook, none of which are addressed in this Form 8-K.